
According to GlobalData, adequate healthcare spending and increasing adoption of immunoassay platforms from companies with high market shares such as…
Out of the 20 top biopharmaceutical companies, 16 reported a drop in quarter-on-quarter (QoQ) market capitalization where eight companies saw…
However, key opinion leaders (KOLs), as per GlobalData, were unanimous in their preference to prescribe established LAIs over the new…
As both lung biopsy methods have been instrumental in improving lung cancer diagnosis, they are expected to see an increased…
LUM-201 increases the amplitude of endogenous pulsatile growth hormone secretion via potent agonism of the growth hormone secretagogue receptor (GHSR),…
Roche/Chugai’s crovalimab and Novartis’s iptacopan hydrochloride are the two late-stage pipeline molecules currently being developed in Japan for aHUS, which…
According to GlobalData’s Pharma Intelligence Center, there are 19 drugs in various phases of clinical development for the treatment of…
GlobalData claims that one of the main reasons for choosing India as the destination is the availability of diverse healthcare…
The data and analytics company maintained that a universal vaccine must target common areas of the virus that are less…
According to GlobalData, the growth will be supported by the US Food and Drug Administration (FDA) approval of Roche’s Vabysmo…
Singapore is a key manufacturing player for a range of advanced medical technologies for global markets, including implanted pacemakers, contact…
The company claims that the CKD market is mainly dominated by cheap, generic drugs, such as angiotensin-converting enzyme (ACE) inhibitors,…
GlobalData’s research reveals that Olympus Corp was the market leader for endoscopy devices, accounting for around 23 percent of the…
Even though intranasal vaccines can produce both local and systemic immunity, there can be challenges around long-lasting immunity, the company…
India has a growing cancer burden as the country is expected to see a 12 percent rise in cancer cases…
The data analytics company’s latest report reveals that the Asia-Pacific region has the third largest market for robotic surgical systems…
The provision of a single vaccine that can protect the population against all prevalent serogroups is the most important opportunity…
The Huntington’s disease pipeline will see exciting new developments over the next decade as disease-modifying drugs transform the market landscape,’…